Author: Castro, M. V.; Santos, K. S.; Apostolico, J. S.; Fernandes, E. R.; Almeida, R. R.; Levin, G.; Magawa, J. Y.; Nunes, J. P. S.; Bruni, M.; Yamamoto, M. M.; Lima, A. C.; Silva, M. V. R.; Matos, L. R. B.; Coria, V. R.; Castelli, E. C.; Scliar, M. O.; Kuramoto, A.; Bruno, F. R.; Jacintho, L. C.; Nunes, K.; Wang, J. Y. T.; Coelho, V. P.; Mitne Neto, M.; Maciel, R. M. B.; Naslavsky, M. S.; Passos-Bueno, M. R.; Boscardin, S. B.; Rosa, D. S.; Kalil, J.; Zatz, M.; Cunha-Neto, E.
Title: Monozygotic twins discordant for severe clinical recurrence of COVID-19 show drastically distinct T cell responses to SARS-Cov-2 Cord-id: 4jqym656 Document date: 2021_3_28
ID: 4jqym656
Snippet: Background. Clinical recurrence of COVID-19 in convalescent patients has been reported, which immune mechanisms have not been thoroughly investigated. Presence of neutralizing antibodies suggests other types of immune response are involved. Methods. We assessed the innate type I/III IFN response, T cell responses to SARS-CoV-2 with IFN{gamma} ELISPOT, binding and neutralizing antibody assays, in two monozygotic twin pairs with one COVID-19 recurrence case. Results. In pair 1, four months after a
Document: Background. Clinical recurrence of COVID-19 in convalescent patients has been reported, which immune mechanisms have not been thoroughly investigated. Presence of neutralizing antibodies suggests other types of immune response are involved. Methods. We assessed the innate type I/III IFN response, T cell responses to SARS-CoV-2 with IFN{gamma} ELISPOT, binding and neutralizing antibody assays, in two monozygotic twin pairs with one COVID-19 recurrence case. Results. In pair 1, four months after a first mild episode of infection for both siblings, one displayed severe clinical recurrence of COVID-19. Twin pair 2 of siblings underwent non-recurring asymptomatic infection. All fours individuals presented similar overall responses, except for remarkably difference found in specific cellular responses. Recurring sibling presented a reduced number of recognized T cell epitopes as compared to the other three including her non-recurring sibling. Conclusions. Our results suggest that an effective SARS-CoV-2-specific T cell immune response is key for complete viral control and avoidance of clinical recurrence of COVID-19. Besides, adaptive immunity can be distinct in MZ twins. Given the rising concern about SARS-CoV-2 variants that evade neutralizing antibodies elicited by vaccination or infection, our study stresses the importance of T cell responses in protection against recurrence/reinfection.
Search related documents:
Co phrase search for related documents- absence presence and adaptive immunity: 1, 2, 3, 4
- absence presence and adaptive innate: 1, 2
- absence presence and lysis buffer: 1, 2, 3, 4, 5
- acute respiratory syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adaptive innate immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and adaptive innate sars immune response: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and additional funding: 1
- acute respiratory syndrome and lysis buffer: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date